Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
Mbio|February 27, 2020
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein GeneYingyun Cai, Chengjin Ye, Benson Cheng, et al.Biorxiv : the Preprint Server for Biology|March 16, 2022
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Desphande, et al.Science Advances|June 26, 2026
A subunit vaccine for multiple respiratory virusesQinzhe Li, Wei-Chiao Huang, Sara H Mahmoud, et al.Journal of Virology|September 8, 2021
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In VivoKevin Chiem, Desarey Morales Vasquez, Jesus A Silvas, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concernMijia Lu, Michelle Chamblee, Yuexiu Zhang, et al.Science Advances|September 22, 2023
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5Brian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapyAlexander M Horspool, Chengjin Ye, Ting Y Wong, et al.Research Square|January 16, 2026
Pulmonary Microvascular Endothelial Antigen Presentation Activates Resident CD8⁺ T Cells to Restrain Influenza Lung InjuryLianghui Zhang, Yuanyun Ao, Kamal Bagale, et al.Journal of Virology|June 16, 2021
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic MiceJesus A Silvas, Desarey Morales Vasquez, Jun-Gyu Park, et al.Plos Pathogens|July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.Pageof 12